SecBot SecBot

NIVF

NewGenIvf Group Ltd
Nasdaq· Services-Misc Health & Allied Services, NEC· Inc. D8· CIK 0001981662 Healthcare & Medical Devices
$1.21 −0.25 (−17.12%)
Oct 26 4:00 PM ET · prev $1.46
Market cap
$1.5M
Nano cap
Median target
$4,066.56
+335979% · range $4,066.56–4,066.56
1 year
−100.0%
from $20,597.76 · Oct 27
30 days
−89.0%
from $11.04
52-week range
$1.19–20,597.76
−100% from high · low Oct 22
Avg volume 20D
4.09M
Sep 30 spike 26.85M
Short interest
70.0K
≈0.2% of shares · +324.1%
Days to cover
1.0
at average volume
Insider net
+$4.2M
2 buyers · 1 seller · 12 mo
Filing reports
19
analyzed by SecBot
SecBot read BEARISH 14 reports · 90 days
Balance 8 bearish · 0 bullish · 2 mixed · 4 neutral oldest → newest, height = score
Avg score ·High conf. 11/14
Strongest BEARISH NewGenIvf Group Ltd has priced a deeply dilutive best-efforts offering of 125,000 Class A Ordinary Shares at…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    2 insiders bought $4.4M. 1 insider sold $119.0K.

  • Short sellersBUILDING

    Short interest +324.1% to 70.0K shares. 1.0 days to cover, ≈0.2% of shares.

  • TrendDOWNTREND

    95% below its 50-day average. New closing low $1.19 on Oct 22.

  • SocialQUIET

    No Reddit mentions this week. Last mention Oct 14.

The Street

12-month targets · 1 analysts

Price is below the lowest target. Median implies +335979%.Targets as of Oct 26, 2026.

Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 23, 2026 Trading halt
Halt Resumed: NIVF — trading resumed after T3 (News and Resumption Times)
Halted 2026-10-22T23:50:00.000Z | Resumed 2026-10-23T13:00:00.000Z
Oct 21, 2026 SEC
NewGenIvf Group Ltd announced a 1-for-8 reverse stock split approved by the Board on October 6, 2026, effective…
6-K — Impact 4/10
Oct 7, 2026 SEC
NewGenIvf Group reported H1 2026 unaudited results showing a net loss of $8.0M vs a profit of $0.7M in H1 2025, with…
6-K — Impact 7/10
Oct 7, 2026 SEC
NewGenIvf Group Ltd announced a 1-for-4 reverse stock split approved by the Board on September 16, 2026, effective…
6-K — Impact 3/10
Oct 5, 2026 Insider
Fong Hei Yue Tina acquired via exercise 49,078 shares
Chief Marketing Officer
Oct 5, 2026 Insider
Siu Wing Fung Alfred acquired via exercise 90,713 shares
Chairman & CEO
Oct 5, 2026 Insider
Siu Wing Fung Alfred acquired via exercise 49,098 shares
Chairman & CEO
Sep 30, 2026 Press
NewGenIVF closed a public offering raising ~$1.25M at $0.07/share, issuing 17.86M shares/pre-funded warrants. The tiny…
Impact 6/10
Reddit
Recent posts
r/pennystocks Neutral 12d ago
14 OCT 2026 , WHAT ARE THE BIGGEST WINNERS AND WHY ?
2 upvotes · 3 comments
r/pennystocks Bullish 24d ago
HERES A HOT 🔥 TIP only comes around once in a lifetime, make 9x times your money 💰 today Buy TICKER NIVF the big boys on Wall Street just confirmed it!! NIVF IS GUNNA SHORT SQEEZE $$$$$
1 upvotes · 0 comments
r/pennystocks Neutral 25d ago
02 OCT 2026 , WHAT ARE THE BIGGEST LOSERS AND WHY ?
1 upvotes · 1 comments
All social signals and their track records

Insider ledger

Form 4
$4.4M
bought · 2 insiders
$119.0K
sold · 1 insider
DateInsiderTypeValue
Oct 5, 2026
Fong Hei Yue Tina
Chief Marketing Officer
EXERCISE49,078 sh
Oct 5, 2026
Siu Wing Fung Alfred
Chairman & CEO
EXERCISE90,713 sh
Oct 5, 2026
Siu Wing Fung Alfred
Chairman & CEO
EXERCISE49,098 sh
Oct 5, 2026
Fong Hei Yue Tina
Chief Marketing Officer
EXERCISE90,713 sh
Oct 5, 2026
Siu Wing Fung Alfred
Chairman & CEO
EXERCISE$13.98
Oct 5, 2026
Fong Hei Yue Tina
Chief Marketing Officer
EXERCISE$13.98
Aug 17, 2026
Fong Hei Yue Tina
Chief Marketing Officer
AWARD272,140 sh
Aug 17, 2026
Siu Wing Fung Alfred
Chairman & CEO
AWARD272,140 sh

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY$1365.12$1365.12–$1365.12+0.0%$65.1M
Next FY$2689.92$2689.92–$2689.92+0.0%$180.4M

Short side

FINRA· Sep 30, 2026
70,041
shares short
+324.1%
vs prior settlement
1.0
days to cover
≈0.2%
of shares outstanding
On the Reg SHO threshold listsince Aug 24, 2026: persistent fails-to-deliver. View list
Trading halts
Oct 22, 2026Resumption ScheduledResumed
Oct 9, 2026Resumption ScheduledResumed
Sep 25, 2026Volatility PauseResumed
Aug 31, 2026Resumption ScheduledResumed
Jul 2, 2026Resumption ScheduledResumed
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Oct 23, 2026
Trading halt
Halt Resumed: NIVF — trading resumed after T3 (News and Resumption Times)
Halted 2026-10-22T23:50:00.000Z | Resumed 2026-10-23T13:00:00.000Z
Oct 22, 2026
Trading halt
Trading Halt: NIVF — T3 (News and Resumption Times)
NewGenIvf Group Limited Os | Market: NASDAQ | Code: T3 — News and Resumption Times
Oct 12, 2026
Trading halt
Halt Resumed: NIVF — trading resumed after T3 (News and Resumption Times)
Halted 2026-10-09T23:50:00.000Z | Resumed 2026-10-12T13:00:00.000Z
Oct 9, 2026
Trading halt
Trading Halt: NIVF — T3 (News and Resumption Times)
NewGenIvf Group Limited Os | Market: NASDAQ | Code: T3 — News and Resumption Times
Sep 30, 2026
Activist
NewGen Announces Closing of $1.25 Million Public Offering
BANGKOK, Oct. 01, 2026 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (the “Company”), a tech-forward, diversified, multi-jurisdictional…

SecBot reports

19 filings · 3 press releases · 1 bullish · 8 bearish · 3 mixed · 7 neutral
All NIVF filing & press-release reports (22)